Member Info for Dr_DMS

Enhertu also comes with a warning for a potentially deadly side effect called interstitial lung disease/pneumonitis. In studies of Enhertu in people with NSCLC and breast cancer, around 12% of patients experienced interstitial lung disease/pneumonitis.

That’s higher than what’s seen with other targeted therapies for lung cancer, Dr. Neal noted.

“Most of the time [interstitial lung disease/pneumonitis] is mild and reversible, but occasionally this could be severe and life-threatening,” Dr. Li said.

Listened again, must have been pre-recorded, seems like they wanted that bit cut out but whoever edited didn't do a very good job, very interesting.....!

Not sure what you are getting at, can you elaborate?

Yep! Same thing as usual :((

Last few results all been good but SP tanked 6% each time, hope this time is different!

I didn't realise this was still such an issue, typical ADCs still have significant side affects.

I guess that's evidenced by the (only) 3-8x conc of chemo in the TME vs plasma, vs 100x for preCision

I have CCL shares (Carnival) that are dual listed, there can be big swings in SP (up or down) when US markets open at 2.30pm GMT, it's very noticeable.

However, they have always been dual listed whilst i've owned them, nit sure what happens if they are only listed on FTSE, then go dual..

I also own shell, they are talking about leaving FTSE to go on NYSE, again different to what Avacta are proposing..

Good question, interested to hear the answers too

Any use?

So the note was nonsense then?

Should do well now fuel prices have dropped significantly and oil predicted to be in the $60-75 range for the forseeable.

Having said that, tensions in the middle east could flare up but SA have given up on the $100 target and ramping up production...

Ah ok, so do the directors own the majority of the shares? (the other 200m)

Have they had any grants etc off the government? Is anything available?

Funny how the narrative has changed, used to be comments were all about the science, but now all about the SP and commercial interests, patience is running thin....

How much would they need to raise at the placing?

Im sure there will be plenty of questions about commercials

Think too many people seriously overestimated potential revenues from mpox, it was never gonna be like Covid....

Novacyt was the only company to have a test for Covid, mpox there are 50+ companies supplying, having said that, if they can get a Clade 1 IVD test produced, it would help.

Having said this, i think the same will keep happening to the SP every time a new outbreak makes mainstream news.

I've got quite a bit invested here since 2020 and also regret not selling out, my sell target was only £1 higher, missed out on a massive profit, but i've learnt so much from this, so i'm taking that as a positive.

I will only invest in AIM now to do a few small trades here and there, it's too risky for me now...

Hopefully the divs will pick up! Doubled on my position on last weeks dip, and managed to average down a few quid, finally into a profit :)

Maybe they think tensions with Iran will kick off....

Good luck with producing more, will just drive the price even lower, outlook is for reduced demand for 2025.

Will just be going into reserves